糖尿病药物-SGLT-2抑制剂专利技术分析

Analysis of patent technology of antidiabetics——SGLT-2 inhibitors

钠-葡萄糖协同转运蛋白2(SGLT-2)抑制剂是治疗2型糖尿病的新型药物,简介钠-葡萄糖协同转运蛋白2抑制剂的研究现状,重点分析钠-葡萄糖协同转运蛋白2抑制剂的专利申请量、申请人、重点专利等,梳理出钠-葡萄糖协同转运蛋白2抑制剂的技术发展过程。

SGLT-2 inhibitors are novel medicines for treating type 2 diabetes.The research status of SGLT-2 inhibitors were reviewed in this paper.The number of SGLT-2 inhibitor related patent applications,as well as the applicants,and important applications were analyzed.The technology development process of SGLT-2 inhibitors were introduced.